Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency  | Penalty Amount |
|---|---|---|---|---|---|---|
| Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $23,000,000 |
| Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
| Warner Chilcott | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $8,000,000 |
| Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $9,000,000 |
| Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
| Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
| Wockhardt Limited | Wockhardt Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $340,000 |
| Wyeth | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $2,100,000 |
| ZLB Behring, L.L.C. | CSL Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
| General Nutrition Centers Inc. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2019 | private lawsuit-federal | $6,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2020 | private lawsuit-federal | $6,315,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2019 | private lawsuit-federal | $2,400,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2017 | private lawsuit-federal | $6,750,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2017 | private lawsuit-federal | $5,000,000 |
| Merck & Co. | Merck | pharmaceuticals | consumer protection violation | 2012 | private lawsuit-state | $39,000,000 |
| Merck, Sharp & Dohme Corp. | Merck | pharmaceuticals | consumer protection violation | 2014 | private lawsuit-federal | $23,000,000 |
| Pharmavite LLC | Otsuka Pharmaceutical | pharmaceuticals | consumer protection violation | 2017 | private lawsuit-federal | $10,975,000 |
| Glenmark Pharmaceuticals | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $14,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $385,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Amgen and Immunex | Amgen | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
| Aventis Pharmaceutical L.P. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
| Dey L.P. | Viatris | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| McNeil-PPC Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2015 | AL-AG | $500,000 |
| Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
| Shering-Plough/Warrick Companies | Merck | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Takeda Pharmaceuticals | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
| TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Biocryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | pharmaceuticals | hazardous waste violation | 2014 | AL-ENV | $11,000 |
| Dey, Inc. | Viatris | pharmaceuticals | fraud | 2004 | AR-AG | $600,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
| Knoll Pharmaceuticals | AbbVie | pharmaceuticals | consumer protection violation | 2001 | AR-AG | $826,957 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | AR-AG | $525,780 |
| Alpharma Animal Health Division | Zoetis | pharmaceuticals | hazardous waste violation | 2002 | AR-ENV | $9,394 |
| Alpharma Animal Health Division | Zoetis | pharmaceuticals | hazardous waste violation | 2001 | AR-ENV | $80,000 |
| Pfizer | Pfizer | pharmaceuticals | consumer protection violation | 2022 | AZ-AG | $124,527 |
| IDEXX Reference Laboratories, Inc. | IDEXX Laboratories | pharmaceuticals | environmental violation | 2009 | AZ-DEQ | $80,000 |
| Phibrochem, Inc. | Phibro Animal Health | pharmaceuticals | export control violation | 2012 | BIS | $31,000 |
| EMD Chemicals, Inc. | Merck KGaA (EMD) | pharmaceuticals | export control violation | 2007 | BIS | $44,000 |
| Sigma Aldrich Research Biochemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | export control violation | 2002 | BIS | $1,760,000 |
| Elan Pharmaceuticals Inc. | Perrigo | pharmaceuticals | export control violation | 2005 | BIS | $31,000 |
| Bristol-Myers Squibb Medical Imaging, Inc. | Bristol-Myers Squibb | pharmaceuticals | export control violation | 2004 | BIS | $16,200 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
| Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | consumer protection violation | 2019 | CA-AG | $760,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | CA-AG | $11,800,000 |
| Mia Rose, Inc. | Nutraceutical International Corp. | pharmaceuticals | air pollution violation | 2014 | CA-ARB | $45,000 |
| Advanced Sterilization Products | Johnson & Johnson | pharmaceuticals | pesticide violation | 2012 | CA-DPR | $25,616 |
| Pfizer Inc. | Pfizer | pharmaceuticals | pesticide violation | 2012 | CA-DPR | $6,720 |
| Schering-Plough Healthcare Products Inc. | Merck | pharmaceuticals | pesticide violation | 2011 | CA-DPR | $28,400 |
| Abbott Laboratories Diagnostics | Abbott Laboratories | pharmaceuticals | pesticide violation | 2007 | CA-DPR | $9,476 |
| Phibro-Tech Inc. | Phibro Animal Health | pharmaceuticals | environmental violation | 2019 | CA-DTSC | $495,000 |
| Neutrogena Corp. | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | CA-DTSC | $416,248 |
| Phibro-Tech Inc. | Phibro Animal Health | pharmaceuticals | hazardous waste violation | 2010 | CA-DTSC | $39,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
| Valeant Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | insurance violation | 2018 | CA-INS | $1,875,000 |
| AbbVie Inc. | AbbVie | pharmaceuticals | consumer protection violation | 2020 | CA-INS | $24,000,000 |
| Amphastar Pharmaceuticals | Amphastar Pharmaceuticals | pharmaceuticals | wage and hour violation | 2011 | CA-LCO | $25,000 |
| Depuy Synthes Sales, Inc. | Johnson & Johnson | pharmaceuticals | wage and hour violation | 2020 | CA-LCO | $57,488 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2015 | CA-MULTI | $506,000 |
| Perrigo Co. | Perrigo | pharmaceuticals | consumer protection violation | 2022 | CA-MULTI | $360,000 |
| Phibro-Tech Inc | Phibro Animal Health | pharmaceuticals | air pollution violation | 2017 | CA-SCAQMD | $19,000 |
| Baxalta US, Inc. | Takeda Pharmaceutical | pharmaceuticals | air pollution violation | 2017 | CA-SCAQMD | $35,000 |
| Abbott Cardiovascular Systems, Inc. | Abbott Laboratories | pharmaceuticals | air pollution violation | 2013 | CA-SCAQMD | $93,700 |
| Abraxis Bioscience, Inc. | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2012 | CA-SCAQMD | $5,000 |
| Abbott Cardiovascular Systems, Inc. | Abbott Laboratories | pharmaceuticals | air pollution violation | 2011 | CA-SCAQMD | $12,000 |
| Actavis Kadian, LLC | AbbVie | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $116,703 |
| Intermune, Inc. | Roche | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $5,641 |
| Intermune, Inc. | Roche | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $16,215 |
| Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2015 | CMS | $5,909 |
| Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2015 | CMS | $9,440 |
| Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2016 | CMS | $10,788 |
| Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2016 | CMS | $12,367 |
| Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2019 | CMS | $12,968 |
| Wockhardt USA | Wockhardt Limited | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2020 | CMS | $111,824 |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2023 | CMS | $31,959 |
| Pfizer | Pfizer | pharmaceuticals | consumer protection violation | 2022 | CO-AG | $137,174 |
| Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
| Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
| Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2011 | CT-ENV | $20,000 |
| Pfizer, Inc. | Pfizer | pharmaceuticals | environmental violation | 2010 | CT-ENV | $31,266 |
| Pfizer Inc. | Pfizer | pharmaceuticals | environmental violation | 2006 | CT-ENV | $40,224 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
| Merck KgaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
| Apotex Corp. | Apotex Corp. | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
| Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
| Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
| St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
| Acclarent Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
